Agonist and Antagonist Receptor Binding

  • Stafford McLean
  • John A. LoweIII
Part of the The Receptors book series (REC)


Substance P (SP), neurokinin A (NKA), and neurokinin B (NKB) are members of the tachykinin family of peptides that share the carboxy terminal sequence Phe-X-Gly-Leu-Met-NH2. These mammalian tachykinins elicit their effects through three different receptors known as NK1NK2and NK3. Pharmacological and biochemical studies suggest that substance P is the preferred endogenous ligand for the NKI receptor, whereas neurokinin A and neurokinin B have highest affinity for NK2 and NK3 receptors, respectively (Buck and Burcher, 1986; Maggio, 1988; Quirion and Dam, 1988; Guard and Watson, 1991). The characterization of the NKINK2and NK3 receptors as distinct sites was confirmed with the cloning and sequencing of separate cDNAs encoding each of the receptors (Masu et al., 1987; Sasai and Nakanishi, 1989; Yokota et al., 1989; Gerard et al., 1990; Hershey and Krause, 1990; Shigemoto et al., 1990; Hershey et al., 1991). The deduced amino acid sequence and hydropathy analysis suggest that all three of the tachykinin receptors contain seven transmembrane spanning domains and sequence similarity with other members of the superfamily of G-proteincoupled receptors. Maximal sequence homology among NKINK2and NK3 receptors is found in the putative core transmembrane domains, whereas homology is lowest at the amino and carboxy terminal ends (Nakanishi, 1991).


Neurokinin Receptor Tachykinin Receptor Hamster Trachea Rabbit Pulmonary Artery Bridgehead Nitrogen 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Advenier, C., Rouissi, N., Nguyen, Q. T., Emonds-Alt, X., Breliere, J.-C., Neliat, G., Naline, E., and Regoli, D. (1992) Neurokinin A (NK2) receptor revisited with SR 48968, a potent non-peptide antagonist.Biochem. Biophys. Res. Commun. 184, 1418–1424.PubMedCrossRefGoogle Scholar
  2. Appell, K. C., Fragale, B. J., Loscig, J., Singh, S., and Tomczuk, B. E. (1992) Antagonists that demonstrate species differences in neurokinin-1 receptors.Mol. Pharmacol. 41, 772–778.PubMedGoogle Scholar
  3. Ariens, E. J., Beld, A. J., Rodrigues de Miranda, J. F., and Simomis, A. M. (1979)The Receptors: A Comprehensive Treatise.Plenum, New York, pp. 33–91.Google Scholar
  4. Bahouth, S. W. and Musacchio, J. M. (1985) Specific binding of [3H]substance P to the rat submaxillary gland. The effects of ions and guanine nucleotides.J. Pharmacol. Exp. Ther. 234, 326–336.PubMedGoogle Scholar
  5. Beaujouan, J. C., Torrens, Y., Saffroy, M., and Glowinski, J. (1988) Neuropeptide K, scyliorhinin I and scyliorhinin II: new tools in the tachykinin receptor field.Eur. J. Pharmacol 151353–354.PubMedCrossRefGoogle Scholar
  6. Beaujouan, J. C., Torrens, Y., Viger, A., and Glowinski, J. (1984) A new type of tachykinin binding site in the rat brain characterized by specific binding of a labeled eledoisin derivative.Mol. Pharmacol. 26, 248–254.PubMedGoogle Scholar
  7. Beresford, I. J. M., Birch, P. J., Hagan, R. M., and Ireland, S. J. (1991) Investigation into species variants in tachykinin NIS receptors by use of the nonpeptide antagonist, CP-96,345.Br. J. Pharmacol. 104, 292–293.PubMedCrossRefGoogle Scholar
  8. Bergstrom, L., Beaujouan, J. C., Torrens, Y., Saffroy, M., Glowinski, J., Lavielle, S., Chassaing, G., Marquet, A., d’Orleans-Juste, P., Dion, S., and Regoli, D. (1987)3H-neurokinin A labels a specific tachykinin-binding site in the rat duodenal smooth muscle.Mol. Pharmacol. 32764–771.PubMedGoogle Scholar
  9. Bergstrom, L., Torrens, Y., Saffroy, M., Beaujouan, J. C., Lavielle, S., Chassaing, G., Morgat, J. L., Glowinski, J., and Marquet, A. (1987) [3H]neurokinin B and1251-BH eledoisin label identical tachykinin binding sites in the rat brain.J. Neurochem. 48, 125–133.PubMedCrossRefGoogle Scholar
  10. Bryce, D. K. and McLean, S. (1991) Differential binding of CP-96,345 across species: possible heterogeneity of the NK-1 tachykinin receptor.Soc. Neurosci. Abs. 17, 804.Google Scholar
  11. Buck, S. H. and Burcher, E. (1986) The tachykinins: a family of peptides with a brood of “receptors.”Trends Pharmacol. Sci 7 65–68.CrossRefGoogle Scholar
  12. Buck, S. H., Burcher, E., Shults, C. W., Lovenberg, W., and O’Donohue, T. L. (1984) Novel pharmacology of substance K-binding sites: a third type of tachykinin receptor.Science 226, 987–989.PubMedCrossRefGoogle Scholar
  13. Buck, S. H., Harbeson, S. L., Hassmann, C. F., Shatzer, S. A., Rouissi, N., Nantel, F., and Van Giersbergen, P. L. (1990) [Leu9yt(CH2NH)Leu10]-neurokinin A (4–10) (MDL 28,564) distinguishes tissue tachykinin peptide NK2receptors.Life. Sci. 47, PL37–PL41.PubMedCrossRefGoogle Scholar
  14. Buell, G., Schulz, M. F., Arkinstall, S. J., Maury, K., Missotten, M., Adami, N., Talabot, F., and Kawashima, E. (1992) Molecular characterisation, expression and localisation of human neurokinin-3 receptor.FEBS Lett. 299, 90–95.PubMedCrossRefGoogle Scholar
  15. Burcher, E. and Buck, S. H. (1986) Multiple tachykinin binding sites in hamster, rat and guinea pig urinary bladder.Eur. J. Pharmacol. 128, 165.PubMedCrossRefGoogle Scholar
  16. Burcher, E., Buck, S. H., Lovenberg, W., and O’Donohue, T. L. (1986) Characterization and autoradiographic localization of multiple tachykinin binding sites in gastrointestinal tract and bladder.J. Pharmacol. Exp. Ther. 236, 819–831.PubMedGoogle Scholar
  17. Burcher, E., Mussap, C. J., Geraghty, D. P., McClure-Sharp, J. M., and Watkins, D. J. (1991) Concepts in characterization of tachykinin receptors.Ann. NY Acad. Sci. 632, 123–136.PubMedCrossRefGoogle Scholar
  18. Cascieri, M. A., Ber, E., Fong, T. M., Sadowski, S., Bansal, A., Swain, C., Seward, E., Frances, B., Burns, D., and Strader, C. D. (1992) Characterization of the binding of a potent, selective, radioiodinated antagonist to the human neurokin-1 receptor.Mol. Pharmacol. 42, 458–463.PubMedGoogle Scholar
  19. Cascieri, M. A., Chicchi, G. G., and Liang, T. (1985) Demonstration of two distinct tachykinin receptors in rat brain cortex.J. Biol. Chem. 260, 1501–1507.PubMedGoogle Scholar
  20. Cascieri, M. A. and Liang, T. (1983) Characterization of the substance P receptor in rat brain cortex membranes and the inhibition of radioligand binding by guanine nucleotides.J. Biol. Chem. 2585158–5164.PubMedGoogle Scholar
  21. Cascieri, M. A. and Liang, T. (1984) Binding of 125I-BH conjugated eledoisin to rat brain cortex membranes-evidence for two classes of tachykinin receptors in the mammalian central nervous system.Life. Sci. 35179–184.PubMedCrossRefGoogle Scholar
  22. Chassaing, G., Lavielle, S., Brunissen, A., Carruette, A., Garret, C., Petitet, F., Saffroy, M., Beaujouan, J. C., Torrens, Y., and Glowinski, J. (1992) [Pro9]SP and [pG1u6Pro9]SP(6–11) interact with two different receptors in the guinea pig ileum as demonstrated with new SP antagonists.Neuropeptides 23 73–79.PubMedCrossRefGoogle Scholar
  23. Conlon, J. M., Deacon, C. F., O’Toole, L., and Thim, L. (1986) Scyliorhinin I and II: two novel tachykinins from dogfish gut.FEBS Lett. 200111–116.PubMedCrossRefGoogle Scholar
  24. Dam, T.-V., Takeda, Y., Krause, J. E., Escher, E., and Quirion, R. (1990) yPreprotachykinin-(72–92)-peptide amide: an endogenous y-preprotachykinin I gene derived peptide which preferentially binds to neurokinin-2 receptors.Proc. Natl. Acad. Sci. USA 87246–250.PubMedCrossRefGoogle Scholar
  25. DeLean, A., Stadel, J. M., and Lefkowitz, R. J. (1980) A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase coupled 3-adrenergic receptor.J. Biol. Chem. 2557108–7117.Google Scholar
  26. Desai, M. C., Lefkowitz, S. L., Thadio, P. F., Longo, K. P., and Snider, R. M. (1992) Discovery of a potent substance P antagonist: recognition of the key molecular determinant.J. Med. Chem. 1354911–4913.CrossRefGoogle Scholar
  27. Dietl, M. M. and Palacios, J. (1991) Phylogeny of tachykinin receptor localization in the vertebrate central nervous system: apparent absence of neurokinin-2 and neurokinin-3 binding sites in the human brain.Brain Res. 539211–222.PubMedCrossRefGoogle Scholar
  28. Dion, S., Rouissi, N., Nantel, F., Drapeau, G., Regoli, D., Naline, E., and Advenier, C. (1990) Receptors for neurokinins in human bronchus and urinary bladder are of the NK-2 type.Eur. J. Pharmacol. 178215–219.PubMedCrossRefGoogle Scholar
  29. Drapeau, G., d’Orleans-Juste, P., Dion, S., Rhaleb, N. E., Rouissi, N. E., and Regoli,D.(1987) Selective agonists for substance P and neurokinin receptors.Neuropeptides 1043–54.PubMedCrossRefGoogle Scholar
  30. Elliott, P. J., Mason, G. S., Stephens-Smith, M., and Hagen, R. M. (1991) Behavioural and biochemical responses following activation of midbrain dopamine pathways by receptor selective neurokinin agonists.Neuropeptides 19119–126.PubMedCrossRefGoogle Scholar
  31. Emonds-Alt, X., Advenier, C., Le Fur, G., and Breliere, J. C. (1993) SR48968, a neurokinin A (NK2) receptor antagonist.Regul. Pept.suppl.1, S4.Google Scholar
  32. Emonds-Alt, X., Vilain, P., Goulaouic, P., Proietto, V., Van Broeck, D., Advenier, C., Naline, E., Neliat, G., Le Fur, G., and Breliere, J. C. (1992) A potent and selective nonpeptide antagonist of the neurokinin A (NK2) receptor.Life. Sci. 50PL101–PL106.PubMedCrossRefGoogle Scholar
  33. Folkers, K., Hakanson, R., Honig, J., Jie-Cheng, X., and Leander, S. (1984) Biological evaluation of substance P antagonists.Br. J. Pharmacol. 83, 449–456.PubMedCrossRefGoogle Scholar
  34. Folkers, K., Rosell, S., Chu, J. Y., Lu, L. A., Tang, P. F., and Ljungqvist, A. (1986) Design and synthesis of antagonists of substance P.Acta Chem. Scand. (B) 40295–302.CrossRefGoogle Scholar
  35. Fong, T. M., Anderson, S. A., Yu, H., Huang, R. R., and Strader, C. D. (1992a) Differential activation of intracellular effector by two isoforms of human neurokinin-1 receptor.Mol. Pharmacol. 4124–30.Google Scholar
  36. Fong, T. M., Yu, H., Huang, R.-R., and Strader, C. D. (1992b) Molecular basis for the species selectivity of the neurokinin-1 receptor antagonists CP-96,345 and RP67580.J. Biol. Chem. 267 25,668–25,671.Google Scholar
  37. Foster, A. C. and Tridgett, R. (1988) Comparison of the binding of radiolabelled neurokinin A and eledoisin in rat cortex synaptic membranes.Br. J. Pharmacol. 94602–608.PubMedCrossRefGoogle Scholar
  38. Garret, C., Carruette, A., Fardin, V., Moussaoui, S., Peyronel, J. F., Blanchard, J. C., and Laduron, P. M. (1991) Pharmacological properties of a potent and selective nonpeptide substance P antagonist.Proc. Natl. Acad. Sci. USA 88,10,208–10,212.PubMedCrossRefGoogle Scholar
  39. Geraghty, D. P., Mussap, C. J., and Burcher, E. (1992) Radioiodinated substance P, neurokinin A, and eledoisin bind predominantly in NK, receptors in guinea pig lung.Mol. Pharmacol. 41147–153.PubMedGoogle Scholar
  40. Gerard, N. P., Eddy, R. L., Jr., Shows, T. B., and Gerard, C. (1990) The human neurokinin A (substance K) receptor. Molecular cloning of the gene, chromosome localization, and isolation of the cDNA from tracheal and gastric tissues.J. Biol. Chem. 2661354.Google Scholar
  41. Gether, U., Johansen, T. E., Snider, R. M., Lowe III, J. A., Yokota, Y., Nakanishi, S., and Schwartz, T. W. (1992) Binding epitopes for peptide and nonpeptide ligands on the NK, (substance P) receptor.Regul. Pept. suppl. 1, S6.CrossRefGoogle Scholar
  42. Gitter, B. D., Waters, D. C., Bruns, R. F., Mason, N. R., Nixon, J. A., and Howbert, J. J. (1991) Species differences in affinities of nonpeptide antagonists for substance P receptors.Eur. J. Pharmacol. 197237–238.PubMedCrossRefGoogle Scholar
  43. Guard, S. and Watson, S. P. (1991) Tachykinin receptor types: classification and membrane signalling mechanisms.Neurochem. Intl. 18149–165.CrossRefGoogle Scholar
  44. Guard, S., Watson, S.P.Maggio, J. E., Too, H. P., and Watling, K. J. (1990) Pharmacological analysis of [3H]-senktide binding to NK3 tachykinin receptors in guinea-pig ileum longitudinal muscle-myenteric plexus and cerebral cortex membranes.Br. J. Pharmacol. 99767–773.PubMedCrossRefGoogle Scholar
  45. Hagan, R. M., Beresford, I. J. M., Elliott, P. J., Ball, D. I., Sheldrick, R. L. G., Ireland, S. J., Pritchard, J. M., and McElroy, A. B. (1992) NK2antagonists and the role of NK2receptors.Regul. Pept. suppl. 1S8.Google Scholar
  46. Henry, J. L. (1987) Discussions of nomenclature for tachykinins and tachykinin receptors, inSubstance P and Neurokinins(Henry, J. S., Couture, R., Cuello, A. C., Pelletier, G., Quirion, R., and Regoli, D., eds.), Springer-Verlag, New York, xvii.CrossRefGoogle Scholar
  47. Hershey, A. D., Dykema, P. E., and Krause, J. E. (1991) Organization, structure and expression of the gene encoding the rat substance P receptor.J. Biol. Chem. 2664366–4374.PubMedGoogle Scholar
  48. Hershey, A. D. and Krause, J. E. (1990) Molecular characterization of a functional cDNA encoding the rat substance P receptor.Science 247958–962.PubMedCrossRefGoogle Scholar
  49. Hirschmann, R., Nicolaou, K. C., Pietranico, S., Salvino, J., Leahy, E. M., Sprengeler, P. A., Furst, G., Smith, A. B., Strader, C.D.Cascieri, M. A., Candelore, M. R., Donaldson, C., et al. (1992) Nonpeptidal peptidomimetics with a ß-D-glucose scaffolding. A partial somatostatin agonist bearing a close structural relationship to a potent substance P antagonist.J. Am. Chem. Soc. 1149217–9218.CrossRefGoogle Scholar
  50. Ingi, T., Kitajima, Y., Minamitake, Y., and Nakanishi, S. (1991) Characterization of ligand-binding properties and selectivities of three rat tachykinin receptors by transfection and functional expression of their cloned cDNAs in mammalian cells.J. Pharmacol. Exp. Ther. 259968–975.PubMedGoogle Scholar
  51. Laufer, R., Gilon, C., Chorev, M., and Selinger, Z. (1986) Characterization of a neurokinin B receptor site in rat brain using a highly selective radioligand.J. Biol. Chem. 261, 10,257–10,263.PubMedGoogle Scholar
  52. Lavielle, S., Chassaing, G., Julien, S., Besseyre, J., and Marquet, A. (1986a) Influence of the amino acids of substance P in the recognition of its receptor: affinities of synthesized substance P analogues for the specific t25I-BHsubstance P binding site on rat brain synaptosomes.Neuropeptides 7191–200.CrossRefGoogle Scholar
  53. Lavielle, S., Chassaing, G., Julien, S., Marquet, A., Bergstrom, L., Beaujouan, J. C., Torrens, Y., and Glowinski, J. (1986b) Specific recognition of SP or NKB receptors by analogues of substance P substituted at positions 8 and 9.Eur. J. Pharmacol. 125461–462.CrossRefGoogle Scholar
  54. Lavielle, S., Chassaing, G., Ploux, O., Loeuillet, D., Besseyre, J., Julien, S., Marquet, A., Convert, O., Beaujouan, J.-C., Torrens, Y., Bergstrom, L., Saffroy, M., et al. (1988) Analysis of tachykinin binding site interactions using constrained analogues of tachykinins.Biochem. Pharmacol. 3741–49.PubMedCrossRefGoogle Scholar
  55. Lee, C.-M., Iversen, L. L., Hanley, M. R., and Sandberg, B. E. B. (1982) The possible existence of multiple receptors for substance P.Naunyn Schmiedeberg’s Arch. Pharmacol. 318281–287.CrossRefGoogle Scholar
  56. Lee, C.-M., Javitch, J. A., and Snyder, S. H. (1983)3H-substance P binding to salivary gland membranes.Mol. Pharmacol. 23563–569.PubMedGoogle Scholar
  57. Lew, R., Geraghty, D. P., Drapeau, G., Regoli, D., and Burcher, E. (1990) Binding characteristics of[ 123 I]BH[Sar9,Met(O2)“]substance P, a new selective radioligand for the NK1receptor.Eur. J. Pharmacol. 18497–108.PubMedCrossRefGoogle Scholar
  58. Lowe, J. A., Drozda, S. E., Snider, R. M., Longo, K. P., Zorn, S. H., Morrone, J., Jackson, E. R., McLean, S., Bryce, D. K., Bordner, J., Nagahisa, A., Kanai, Y., et al. (1992) The discovery of (2S,3S)-cis-(diphenylmethyl)-N- [(2-methoxy phenyl)methyl]-1-azabicyclo[2.2.2}-octan-3-amine as a novel, nonpeptide substance P antagonist.J. Med. Chem. 352591–2600.PubMedCrossRefGoogle Scholar
  59. Lowe, J. A., Drozda, S. E., Snider, R. M., Longo, K. P., and Bordner, J. (1991) Preparation and radiolabelling of CP-96,345, the first nonpeptide substance P antagonist.Biorg. Med. Chem. Lett. 1129–132.CrossRefGoogle Scholar
  60. Luber-Narod, J., Boyd, N. D., and Leeman, S. E. (1990) Guanine nucleotides decrease the affinity of substance P binding to its receptor.Eur. J. Pharmacol. 188185–191.PubMedCrossRefGoogle Scholar
  61. MacDonald, S. G. and Boyd, N. D. (1989) Regulation of substance P receptor affinity by guanine nucleotide-binding proteins.J. Neurochem. 53264–272.PubMedCrossRefGoogle Scholar
  62. Maggi, C. A., Patacchini, R., Giuliani, S., Rovero, P., Dion, S., Regoli, D., Giachetti, A., and Meli, A. (1990) Competitive antagonists discriminate between NK2tachykinin receptor subtypes.Br. J. Pharmacol. 100, 589–592.PubMedCrossRefGoogle Scholar
  63. Maggio, J. E. (1988) Tachykinins.Annu. Rev. Neurosci. 1113–28.Google Scholar
  64. Mantyh, C. R. (1984) The autoradiographic distribution of kassin and substance K binding sites is different from the distribution of substance P binding sites in brain.Eur. J. Pharmacol. 102361–364.PubMedCrossRefGoogle Scholar
  65. Masu, Y., Nakayama, K., Tamaki, H., Harada, Y., Kuno, M., and Nakanishi, S. (1987) cDNA cloning of bovine substance-K receptor through oocyte expression system.Nature 329836–838.PubMedCrossRefGoogle Scholar
  66. McElroy, A. B., Clegg, S. P., Deal, M. J., Ewan, G.B.Hagan, R. M., Ireland, S. J., Jordan, C. C., Porter, B., Ross, B. C., and Ward, P. (1992) Highly potent and selective heptapeptide antagonists of the neurokinin NK-2 receptor.J. Med. Chem. 352582–2591.PubMedCrossRefGoogle Scholar
  67. McKnight, A. T., Maguire, J. J., Elliott, N. J., Fletcher, A. E., Foster, A. C., Tridgett, R., Williams, B. J., Longmore, J., and Iversen, L. L. (1991) Pharmacological specificity of novel, synthetic cyclic peptides as antagonists at tachykinin receptors.Br. J. Pharmacol. 104355–360.PubMedCrossRefGoogle Scholar
  68. McLean, S., Ganong, A., Seymour, P. A., Snider, R. M., Desai, M., Rosen, T., Bryce, D. K., Longo, K. P., Reynolds, L. S., Robinson, G., Schmidt, A. W., Siok, C., et al. (1992) Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin NKSreceptor.Regul. Pept. suppl. 1S 120.Google Scholar
  69. McLean, S., Ganong, A. H., Seeger, T. F., Bryce, D. K., Pratt, K. G., Reynolds, L. S., Siok, C. J., Lowe, J. A., and Heym, J. (1991) Activity and distribution of binding sites in brain of a nonpeptide substance P (NK1) receptor antagonist.Science 251437–439.PubMedCrossRefGoogle Scholar
  70. Minneman, K. P. (1988) a1-Adrenergic receptor subtypes, inositol phosphates, and sources of cell Cat+.Pharmacol Rev. 4087–119.PubMedGoogle Scholar
  71. Mussap, C. J. and Burcher, E. (1990) [125I]-BH scyliorhinin II: a novel, selective radioligand for the tachykinin NK3receptor in rat brain.Peptides 11827–836.Google Scholar
  72. Mussap, C. J. and Burcher, E. (1991) Multiple tachykinin receptors in rat submandibular gland.Ann. NY Acad. Sci 632 447–451.PubMedCrossRefGoogle Scholar
  73. Nakanishi, S. (1991) Mammalian tachykin receptors.Annu. Rev. Neurosci. 14123–136.PubMedCrossRefGoogle Scholar
  74. Patacchini, R., Astolfi, M., Quartara, L., Rovero, P., Giachetti, A., and Maggi, C. A. (1991) Further evidence for the existence of NK2tachykinin receptor subtypes.Br. J. Pharmacol. 10491–96.PubMedCrossRefGoogle Scholar
  75. Petitet, F., Beaujouan, J. C., Saffroy, M., Torrens, Y., Chassaing, G., Lavielle, S., Besseyre, J., Garret, C., Carruette, A., and Glowinski, J. (1991) Further demonstration that [Pro9]-substance P is a potent and selective ligand of NK-1 tachykinin receptors.J. Neurochem. 56879–889.PubMedCrossRefGoogle Scholar
  76. Poncelet, M., Gueudet, C., Emonds-Alt, X., Breliere, J. C., Le Fur, G., and Soubrie, P. (1993) Turning behaviour induced in mice by a neurokinin A receptor agonist: stereoselective blockade by SR 48968, a no peptide receptor antagonist.Neurosci. Lett. 14940–42.PubMedCrossRefGoogle Scholar
  77. Quirion, R. and Dam, T.-V. (1985) Multiple tachykinin receptors in guinea pig brain. High densities of substance K (neurokinin A) binding sites in substantia nigra.Neuropeptides 6191–204.PubMedCrossRefGoogle Scholar
  78. Quirion, R. and Dam, T.-V. (1988) Multiple neurokinin receptors: recent developments.Regul. Pept. 22, 18–25.CrossRefGoogle Scholar
  79. Quirion, R., Dam, T.-V. and Guard, S. (1991) Selective neurokinin receptor radioligands.Ann. NYAcad. Sci. 632137–144.CrossRefGoogle Scholar
  80. Regoli, D., Drapeau, G., Dion, S., and Couture, R. (1988) New selective agonists for neurokinin receptors: pharmacological tools for receptor characterization.Trends Pharmacol. Sci. 9290–295.PubMedCrossRefGoogle Scholar
  81. Renzetti, A. R., BarsacchiP.Criscuoli, M., and Lucacchini, A. (1991) Characterization of NK-3 binding sites in rat and guinea pig cortical membranes by the selective ligand [3H]senktide. Neuropeptides 18107–114.PubMedCrossRefGoogle Scholar
  82. Rodbell, M. (1980) The role of hormone receptors and GTP-regulatory proteins in membrane transduction.Nature 28417–22.PubMedCrossRefGoogle Scholar
  83. Rovero, P., Pestellini, V., Maggi, C. A., Patacchini, R., Regoli, D., and Giachetti, A. (1990a) A highly selective NK-2 tachykinin receptor antagonist containing Dtryptophan.Eur. J. Pharmacol. 175113–115.CrossRefGoogle Scholar
  84. Rovero, P., Pestellini, V., Patacchini, R., Giuliani, S., Maggi, C. A., Meli, A., and Giachetti, A. (1990b) Synthesis and biological activity of NK-2 selective tachykinin antagonists containing d-tryptophan.Peptides 11619,620.Google Scholar
  85. Sachais, B. S., Snider, R. M., Lowe III, J. A., and Krause, J. E. (1993) Molecular basis for the species selectivity of the substance P antagonist CP-96,345.J. Biol. Chem. 2682319–2323.PubMedGoogle Scholar
  86. Saffroy, M., Beaujouan, J. C., Torrens, Y., Besseyre, J., Bergstrom, L., and Glowinski, J. (1988) Localization of tachykinin binding sites (NK1, NK2, NK3 ligands) in the rat brain.Peptides 9, 227–241.PubMedCrossRefGoogle Scholar
  87. Sasai, Y. and Nakanishi, S. (1989) Molecular characterization of rat substance K receptor and its mRNA.Biochim. Biophys. Acta 165695–702.Google Scholar
  88. Schilling, W., Bittiger, H., Brugger, F., Criscione, L., Hauser, K., Ofner, S., Olpe, H. R., Vassout, A., and Veenstra, S. (1992) Approaches towards the design and synthesis of nonpeptidic substance P antagonists.XIIth International Symposium on Medicinal ChemistrySept. 13–17, ML-11.3-ML-11.0.Google Scholar
  89. Seabrook, G. R., Main, M., Bowery, B., Wood, N., and Hill, R. G. (1992) Differences in neurokinin receptor pharmacology between rat and guinea pig superior cervical ganglia.Br. J. Pharmacol. 105923–928.CrossRefGoogle Scholar
  90. Shigemoto, R., Yokota, Y., Tsuchida, K., and Nakanishi, S. (1990) Cloning and expression of a rat neuromedin K receptor cDNA.J. Biol. Chem. 265623–628.PubMedGoogle Scholar
  91. Snider, R. M., Constantine, J. W., Lowe, J. A., Longo, K. P., Lebel, W. S., Woody, H. A., Drozda, S. E., Desai, M. C., Vinick, F. J., Spencer, R. W., and Hess, H-J. (1991) A potent nonpeptide antagonist of the substance P (NKS) receptor.Science 251435–437.PubMedCrossRefGoogle Scholar
  92. Sundelin, J. B., Provvedini, D. M., Wahlestedt, C. R., Laurell, H., Pohl, J. S., and Peterson, P. A. (1992) Molecular cloning of the murine substance K and substance P receptor genes.Eur. J. Biochem. 203625–631.PubMedCrossRefGoogle Scholar
  93. Tabart, M., Peyronel, J. F., Truchon, A., Moutonnier, C., Dubroeucq, M. C., Fardin, V., Carruette, A., and Garret, C. (1992) Perhydroisoindolone derivatives: a new class of potent and selective nonpeptide NK1antagonists.Xllth International Symposium on Medicinal Chemistry, Sept. 13–17, P-190.A-P-190.0 (Abstract).Google Scholar
  94. Takeda, Y., Blount, P., Sachais, B. S., Hershey, A. D., Raddatz, R., and Krause, J. E. (1992) Ligand binding kinetics of substance P and neurokinin A receptors stably expressed in Chinese hamster ovary cells and evidence for differential stimulation of inositol 1,4,5-trisphosphate and cyclic AMP second messenger responses.J. Neurochem. 59, 740–745.PubMedCrossRefGoogle Scholar
  95. Takeda, Y., Chou, K. B., Takeda, J., Sachais, B. S., and Krause, J. E. (1991) Molecular cloning, structural characterization and functional expression of the human substance P receptor.Biochem. Biophys. Res. Commun. 1791232–1240.PubMedCrossRefGoogle Scholar
  96. Torrens, Y., Beaujouan, J. C., Viger, A., and Glowinski, J. (1983) Properties of a125I-SP derivative binding to synaptosomes from various brain structures and the spinal cord of the rat.Naunyn Schmiedeberg’s Arch. Pharmacol. 324134–139.CrossRefGoogle Scholar
  97. Torrens, Y., Lavielle, S., Chassaing, G., Marquet, A., Glowinski, J., and Beaujouan, J. C. (1984) Neuromedin K, a tool to further distinguish two central tachykinin binding sites.Eur. J. Pharmacol. 102381,382.Google Scholar
  98. Tousignant, C., Guillemette, G., Drapeau, G., Telemaque, S., Dion, S., and Regoli, D. (1990)125I-BH[Sar9Met(O2)11]-SP, a new selective ligand for the NK-1 receptor in the central nervous system.Brain Res. 524 263–270.PubMedCrossRefGoogle Scholar
  99. Tousignant, C., Guillemette, G., and Regoli, D. (1991) Binding sites for rH][Sar9Met(02)11]substance P in rat brain and guinea pig ileum.Brain Res. 560 1–11.PubMedCrossRefGoogle Scholar
  100. Van Giersbergen, P. L., Shatzer, S. A., Henderson, A. K., Lai, J., Nakanishi, S., Yamamura, H.I.and Buck, S. H. (1991) Characterization of a tachykinin peptide NK2receptor transfected into murine fibroblast B82 cells.Proc. Natl. Acad. Sci. USA 881661–1665.PubMedCrossRefGoogle Scholar
  101. Venepalli, B. R., Aimone, L. D., Appell, K. C., Bell, M. R., Dority, J. A., Goswami, R., Hall, P. L., Kumar, V., Lawrence, K. B., and Logan, M. E. (1992) Synthesis and substance P receptor binding activity of androstano[3,2-b]pyrimido[1,2-a]benzimidazoles.J. Med. Chem. 35374–378.PubMedCrossRefGoogle Scholar
  102. Watling, K. J., Guard, S., Howson, W., and Walton, L. (1991) Inhibition of binding to tachykinin NK1receptor sites in rat, guinea-pig, and human brain by the nonpeptide substance P antagonist (±)CP-96,345.Br. J. Pharmacol. 10427P.Google Scholar
  103. Watson, S. P., Sandberg, B. E. B., Hanley, M. R., and Iversen, L. L. (1983) Tissue selectivity of substance P alkyl esters: suggesting multiple receptors.Eur. J. Pharmacol. 8777–84.PubMedCrossRefGoogle Scholar
  104. Wormser, U., Laufer, R., Hart, Y., Chorev, M., Gilon, C., and Selinger, Z. (1986) Highly selective agonists for substance P receptor subtypes.EMBO J. 52805–2808.PubMedGoogle Scholar
  105. Yokota, Y., Akazawa, C., Ohkubo, H., and Nakanishi, S. (1992) Delineation of structural domains involved in the subtype specificity of tachykinin receptors through chimeric formation of substance P/substance K receptors.EMBO J. 11 3585–3591.PubMedGoogle Scholar
  106. Yokota, Y., Sasai, Y., Tanaka, K., Fujiwara, T., Tsuchida, K., Shigemoto, R., Kakizuka, A., Ohkubo, H., and Nakanishi, S. (1989) Molecular characterization of a functional cDNA for rat substance P receptor.J. Biol. Chem. 264,17,649–17,652.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Stafford McLean
  • John A. LoweIII

There are no affiliations available

Personalised recommendations